Toggle navigation
Home
Search
Services
Blog
Contact
About
Medications Development for Stimulant Dependence (MDS)
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Telemedicine Enhanced Asthma Management - Uniting Providers (TEAM-UP)
Cortical Circuitry for Top-Down Selection of Visual Inputs
P-1: 5A-Reductase Inhibition in Intermittent Androgen Ablation Therapy in Pros
Neural Crest Disorders in Spina Bifida Patients
Hispanic Recruitment/Spanish Proficiency Project
Recently added grants:
Overcoming Pyrazinamide Resistance with Pyrazinoate-Cephalosporin Conjugates
Core B: Industrialization Core
Mechanisms of immune dysregulation in human PI3Kgamma deficiency
In Vivo Efficacy Testing Core
Project I: Discovery and Evaluation of Antibodies and Cocktails
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research and Development Contracts (N01)
Project #
N01DA38824-21-0-2
Application #
7581649
Study Section
Project Start
2003-01-17
Project End
2008-01-16
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 DA
Medications Development for Stimulant Dependence (MDS)
/ University of California Los Angeles
$223,660
NIH 2007
N01 DA
Medications Development for Stimulant Dependence (MDS)
Ling, Walter /
$1,202,203
NIH 2007
N01 DA
/
NIH 2007
N01 DA
Medications Development for Stimulant Dependence (MDS)
/
Comments
Be the first to comment on this grant